01Dec
Americas Antitrust Review 2021
Covid-19 has made 2020 into a year like no other with ‘stay at home’ orders and working from home the new normal. Nonetheless, the tech and pharma industries continued to attract immense antitrust scrutiny, with daily reports in the media and pressure from politicians to address what some perceive to be anticompetitive mergers by digital platforms and pharmaceutical companies, even while innovation in both sectors continues at breakneck speed. In this article, we discuss some of the most...
By:
Cooley LLP
Related
Amazon closed out the trading day yesterday as an official member of the $1 trillion club for the fi...
Read More >
Following the most recent Court Order, EEOC has provided the court with a current update as to its c...
Read More >
The Digitalization Act, which entered into force on January 19, 2021, substantially extends the scop...
Read More >
The United States Supreme Court finally clarified its 11-year-old “clear evidence” standard for ph...
Read More >
The U.S. government recently reminded employers that the consequences stemming from worker safety vi...
Read More >
Any employer that has faced a wage & hour lawsuit in California knows that minor violations can quic...
Read More >